Evaluation of bone turnover/quality markers and bone mineral density (BMD) in prostate cancer patients treated by androgen deprivation therapy with or without denosumab

被引：0
|
作者：
Miyazawa, Y. [1 ]
Syuto, T. [1 ]
Sekine, Y. [1 ]
Nomura, M. [1 ]
Koike, H. [1 ]
Matsui, H. [1 ]
Shibata, Y. [1 ]
Ito, K. [1 ]
Suzuki, K. [1 ]
机构：
[1] Gunma Univ, Urol, Maebashi, Gunma, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2017年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PP131
引用
收藏
页码：104 / 104
页数：1
相关论文
共 50 条
  • [31] Bone mineral density in men on long term androgen deprivation therapy for prostate cancer
    Button, Mick
    Stone, Mike
    Pettit, Rebecca
    Ellawaya, Rebekah
    Staffurth, John
    CANCER TREATMENT REVIEWS, 2008, 34 : S80 - S81
  • [32] Bone mineral density testing after initiation of androgen deprivation therapy for prostate cancer
    Hu, Jason
    Dragomir, Alice
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 521 - 521
  • [33] Bone mineral density in Nigerian men on androgen deprivation therapy for advanced prostate cancer
    Olufemi Olayide Ojewuyi
    Stephen Odunayo Ikuerowo
    Emmanuel Ajibola Jeje
    Oladipo Adeboluji Adewole
    Abimbola Ayodeji Abolarinwa
    Olufunmilade Akinfolarin Omisanjo
    African Journal of Urology, 2020, 26
  • [34] Effects of Denosumab vs Alendronate on Bone Mineral Density (BMD), Bone Turnover Markers (BTM), and Safety in Women Previously Treated with Alendronate.
    Kendler, D. L.
    Benhamou, C. L.
    Brown, J. P.
    Lillestol, M.
    Roux, C.
    Man, H. S.
    Siddhanti, S.
    Martin, J. San
    Bone, H. G.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S473 - S473
  • [35] Bone mineral density in Nigerian men on androgen deprivation therapy for advanced prostate cancer
    Ojewuyi, Olufemi Olayide
    Ikuerowo, Stephen Odunayo
    Jeje, Emmanuel Ajibola
    Adewole, Oladipo Adeboluji
    Abolarinwa, Abimbola Ayodeji
    Omisanjo, Olufunmilade Akinfolarin
    AFRICAN JOURNAL OF UROLOGY, 2020, 26 (01)
  • [36] Bone mineral density changes on androgen deprivation therapy for prostate cancer and response to antiresorptive therapy
    S Yaturu
    S DjeDjos
    G Alferos
    C Deprisco
    Prostate Cancer and Prostatic Diseases, 2006, 9 : 35 - 38
  • [37] Bone mineral density changes on androgen deprivation therapy for prostate cancer and response to antiresorptive therapy
    Yaturu, S
    DjeDjos, S
    Alferos, G
    Deprisco, C
    PROSTATE CANCER AND PROSTATIC DISEASES, 2006, 9 (01) : 35 - 38
  • [38] Relationship Between Bone Mineral Density and Androgen-deprivation Therapy in Japanese Prostate Cancer Patients
    Yuasa, Takeshi
    Maita, Shinya
    Tsuchiya, Norihiko
    Ma, Zhiyong
    Narita, Shintaro
    Horikawa, Yohei
    Yamamoto, Shinya
    Yonese, Junji
    Fukui, Iwao
    Takahashi, Shunji
    Hatake, Kiyohiko
    Habuchi, Tomonori
    UROLOGY, 2010, 75 (05) : 1131 - 1137
  • [39] RELATIONSHIP BETWEEN BONE MINERAL DENSITY AND ANDROGEN-DEPRIVATION THERAPY IN JAPANESE PROSTATE CANCER PATIENTS
    Yuasa, Takeshi
    Maita, Shinya
    Tsuchiya, Norihiko
    Takahashi, Shunji
    Hatake, Kiyohiko
    Fukui, Iwao
    Habuchi, Tomonori
    JOURNAL OF UROLOGY, 2010, 183 (04): : E335 - E335
  • [40] Evaluation of bone mass density on patients with prostate cancer prior to the start of androgen deprivation therapy
    Ziaran, S.
    Goncalves, F. M.
    Wendl, J.
    Trebaticky, B.
    Breza, J. Sn
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2009, 110 (09): : 559 - 562
12345